Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

• Manoj M. Lalu,

  Affiliations Department of Anesthesiology, University of Ottawa, Ottawa, Canada, The Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada

  ⨯
• Lauralyn McIntyre ,

  * E-mail: lmcintyre@ottawahospital.on.ca

  Affiliations Department of Medicine (Division of Critical Care), University of Ottawa, Ottawa, Canada, The Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada

  ⨯
• Christina Pugliese,

  Affiliation The Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada

  ⨯
• Dean Fergusson,

  Affiliation The Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada

  ⨯
• Brent W. Winston,

  Affiliation Department of Critical Care Medicine, University of Calgary, Calgary, Canada

  ⨯
• John C. Marshall,

  Affiliation Department of Surgery (Critical Care), University of Toronto, Toronto, Canada

  ⨯
• John Granton,

  Affiliation Department of Medicine (Critical Care), University of Toronto, Toronto, Canada

  ⨯
• Duncan J. Stewart, for the Canadian Critical Care Trials Group

  Affiliations Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, Canada, Department of Cell and Molecular Medicine, University of Ottawa, Ottawa, Canada

  ⨯